News Snapshot:
CanSino has said it is also in talks with Russia, Brazil and Chile to launch Phase III trials in those countries Reuters 10:34 IST It is the first COVID-19 vaccine patent granted by China, state-owned newspaper People's Daily reported on Sunday China's vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the country's intellectual property regulator. It is the first COVID-19 vaccine patent granted by China, state-owned newspaper People's Daily reported on Sunday. The paper cited documents published by China's National Intellectual Property Administration saying...
